Liquidia (LQDA) Return on Capital Employed Growth (3y) (2024 - 2026)
Liquidia (LQDA) Return on Capital Employed Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.62 Bn | 23.56 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | 1,902.00 |
| 10 | Liquidia | 7.74 Bn | 7.51 Bn | 121.79 Mn | 4,862.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,862.00 |
| Dec 31, 2025 | 84.00 |
| Sep 30, 2025 | -3,151.00 |
| Jun 30, 2025 | -4,602.00 |
| Mar 31, 2025 | -3,014.00 |
| Dec 31, 2024 | -2,302.00 |
| Sep 30, 2024 | -2,132.00 |
| Jun 30, 2024 | -818.00 |
| Mar 31, 2024 | -638.00 |